Okay, I will analyze the provided government policy text and generate a report following the specified structure.
**Report on National Pharmaceutical Pricing Authority (NPPA) Orders Dated November 26, 2021**
**1. Executive Summary:**
This report analyzes two orders (S.O. 4884(E) and S.O. 4885(E)) issued by the National Pharmaceutical Pricing Authority (NPPA) on November 26, 2021. The orders concern the fixing and revising of retail and ceiling prices for various pharmaceutical formulations under the Drugs Prices Control Order (DPCO), 2013. One order (S.O. 4884(E)) sets or revises the retail prices for specific formulations, including Telmisartan, Cefixime, and Tacrolimus. The second order (S.O. 4885(E)) sets or revises the ceiling prices for Methylthioninium chloride and Hydroxocobalamin injections. The orders aim to regulate the prices of essential medicines, ensuring affordability and availability, and mandates compliance from manufacturers, retailers, and distributors. The key finding is that the orders specify revised pricing structures and impose requirements for price display and reporting.
**2. Introduction:**
This report provides an overview and analysis of two orders issued by the National Pharmaceutical Pricing Authority (NPPA) on November 26, 2021, concerning price regulation of pharmaceutical formulations. The analysis is based solely on the provided text of the orders.
**3. Policy Overview:**
* **Core Objective(s):** Based on the text, the core objectives of these orders are to:
* Fix and regulate the retail and ceiling prices of specified pharmaceutical formulations.
* Ensure that manufacturers, retailers, and distributors comply with the price regulations set by the NPPA under the DPCO, 2013.
* Ensure affordability and accessibility of essential medicines.
**4. Background and Rationale:**
The orders likely address the need for ongoing price regulation within the pharmaceutical sector to ensure that essential medicines are available at reasonable prices. Without price controls, manufacturers might set prices that are unaffordable for the general public. The DPCO, 2013, provides the framework for this price regulation, and these orders represent specific actions taken by the NPPA to implement that framework.
**5. Key Provisions / Changes:**
These are **two** price notification orders. Therefore, I will address key provisions separately:
**S.O. 4884(E) - Retail Price Fixation/Revision:**
* Specifies the retail prices (exclusive of Goods and Services Tax) for 47 formulations (detailed in the table within the order). The table includes the name of the formulation, its strength, unit, manufacturer/marketing company, and the retail price in Rupees.
* The manufacturers of the mentioned new drugs must fix the retail price as specified.
* Allows manufacturers to add Goods and Services Tax (GST) to the retail price only if they have actually paid it or if it is payable to the Government.
* Mandates that manufacturers determine the retail price for a pack of the formulation according to the specified retail price per unit, following the provisions of paragraph 11 of the DPCO, 2013.
* Requires manufacturers to issue a price list in Form V to the NPPA via IPDMS and to submit a copy to the State Drug Controller and dealers, as per paragraph 24 of the DPCO, 2013.
* Specifies display of price list as per para 24(4) of DPCO 2013.
* Indicates the retail prices apply only to the manufacturers who have applied for price fixation/revision.
* States consequences for non-compliance and overcharging which will result in being liable to deposit the overcharged amount.
* Supersedes any previous price orders fixing ceiling or retail prices for the listed formulations.
**S.O. 4885(E) - Ceiling Price Fixation/Revision:**
* Fixes the ceiling prices (exclusive of Goods and Services Tax) for two formulations: Methylthioninium chloride Injection and Hydroxocobalamin Injection, specifying the dosage form, strength, unit, and ceiling price in Rupees.
* Requires all manufacturers of scheduled formulations selling branded or generic versions at a price higher than the ceiling price to revise prices downwards.
* Requires manufacturers with existing MRP lower than the ceiling price to maintain the existing MRP.
* Specifies that manufacturers determine the ceiling price for a pack of the formulation according to the specified ceiling price per unit.
* Mandates that manufacturers issue a price list in Form V to the NPPA via IPDMS and to submit a copy to the State Drug Controller and dealers, as per paragraph 24 of the DPCO, 2013.
* Specifies display of price list as per para 24(4) of DPCO 2013.
* Requires an existing manufacturer of a scheduled formulation launches a new drug to apply for prior price approval of such new drug.
* Requires manufacturers to furnish quarterly returns and any intent to discontinue production to the NPPA.
* States consequences for non-compliance and overcharging which will result in being liable to deposit the overcharged amount.
* Supersedes any previous price orders fixing ceiling or retail prices for the listed formulations.
**6. Target Audience and Stakeholders:**
The primary target audience and stakeholders are:
* **Pharmaceutical Manufacturers:** Those producing and marketing the specific formulations listed in the tables within both orders.
* **Marketing Companies:** Companies involved in the marketing and distribution of the listed formulations.
* **Retailers and Distributors:** Entities selling the formulations to consumers.
* **State Drug Controllers:** State regulatory bodies responsible for enforcing drug price control.
* **Consumers:** The ultimate beneficiaries of price regulation, who will have access to medicines at regulated prices.
**7. Implementation Aspects (Inferred):**
* **Responsible agency/bodies mentioned:** The National Pharmaceutical Pricing Authority (NPPA) is the primary body responsible for implementing and enforcing these orders. State Drug Controllers also play a role in ensuring compliance at the state level.
* **Timelines or procedures specified:**
* Manufacturers are required to issue price lists in Form V from the date of notification.
* Retailers and distributors must display price lists as furnished by the manufacturer.
* Manufacturers of scheduled formulations shall furnish quarterly return to the NPPA.
* Any manufacturer intending to discontinue production must furnish information to the NPPA at least six months prior to the intended date of discontinuation.
* The IPDMS (Integrated Pharmaceutical Database Management System) is used for submitting price lists to the NPPA.
**8. Expected Outcomes / Impact of Changes:**
* **Intended outcomes:** The likely intended outcomes are:
* Greater affordability of the specified pharmaceutical formulations for consumers.
* Increased compliance with DPCO, 2013 regulations among pharmaceutical manufacturers, retailers, and distributors.
* Standardized and transparent pricing for the listed medications.
**9. Conclusion:**
The NPPA orders S.O. 4884(E) and S.O. 4885(E), both dated November 26, 2021, are significant regulatory actions aimed at controlling the prices of essential pharmaceutical formulations. They mandate specific price revisions, reporting requirements, and display obligations for manufacturers, retailers, and distributors. These orders are a continuation of the NPPA's efforts to ensure access to affordable medicines within the framework of the DPCO, 2013. Compliance with these orders is crucial for all affected stakeholders in the pharmaceutical industry.
Key Entities Referenced
NEW DELHI : Location where the notification was issued.
Drugs Prices Control Order, 2013 : A legal document that empowers the NPPA to fix prices of essential medicines. Referred to as DPCO, 2013
National Pharmaceutical Pricing Authority : A government regulatory agency in India that fixes prices of pharmaceutical products. Referred to as NPPA.
Ministry of Chemicals and Fertilizers : The Government of India ministry under which the Department of Pharmaceuticals and NPPA operate.
Department of Pharmaceuticals : The department within the Ministry of Chemicals and Fertilizers responsible for policies related to the pharmaceutical sector.
Essential Commodities Act, 1955 : An act of the Parliament of India to provide, in the interests of the general public, for the control of the production, supply, and distribution of, and trade and commerce, in certain commodities
Ms Windlas Biotech Pvt. Ltd. : Manufacturer and Marketing company
Ms Mankind Pharma Ltd. : Manufacturer and Marketing company
Telmisartan IP : Pharmaceutical Product
Chlorthalidone IP : Pharmaceutical Product
Ms. Hema Laboratories Pvt. Ltd. : Manufacturer and Marketing company
Ms Softdeal Pharmaceuticals Pvt. Ltd. : Manufacturer and Marketing company
Cefixime IP : Pharmaceutical Product
Ms Helios Pharmaceuticals : Manufacturer and Marketing company
Ms Panacea Biotec Pharma Limited : Manufacturer and Marketing company
Tacrolimus IP : Pharmaceutical Product
Ms Acme Lifetech LLP : Manufacturer and Marketing company
Ms Troikaa Pharmaceuticals Ltd. : Manufacturer and Marketing company
Etoricoxib IP : Pharmaceutical Product
Paracetamol IP : Pharmaceutical Product
Ms Ravenbhel Healthcare Pvt. Ltd. : Manufacturer and Marketing company
Ms Micro Labs Ltd. : Manufacturer and Marketing company
Metoprolol Succinate IP : Pharmaceutical Product
Metoprolol Tartrate : Pharmaceutical Product
Ms USV Private Limited : Manufacturer and Marketing company
Cholecalciferol IP : Pharmaceutical Product
Ms Pure and Cure Healthcare Pvt. Ltd. : Manufacturer and Marketing company
Dr. Reddy's Laboratories Ltd. : Manufacturer and Marketing company
Cilnidipine IP : Pharmaceutical Product
Ms Eris Lifesciences Limited : Manufacturer and Marketing company
Glimepiride IP : Pharmaceutical Product
J. B. Chemicals Pharmcaeuticals Ltd. : Manufacturer and Marketing company
Metformin Hydrochloride IP : Pharmaceutical Product
Ms Akums Drugs Pharmaceuticals Ltd. : Manufacturer and Marketing company
Amlodipine Besylate IP : Pharmaceutical Product
Ms Ipca Laboratories Limited : Manufacturer and Marketing company
Azelnidipine IP : Pharmaceutical Product
Ms Synokem Pharmaceuticals Ltd. : Manufacturer and Marketing company
Cadila Pharmaceuticals Ltd. : Manufacturer and Marketing company
Rosuvastatin Calcium IP : Pharmaceutical Product
Clopidogrel Bisulphate IP : Pharmaceutical Product
Aspirin IP : Pharmaceutical Product
Ms Ajanta Pharma Limited : Manufacturer and Marketing company
Ivabradine Hydrochloride : Pharmaceutical Product
Ms Curetech Skincare : Manufacturer
Lignocaine Hydrochloride IP : Pharmaceutical Product
Chlorhexidine Gluconate IP : Pharmaceutical Product
Metronnidazole : Pharmaceutical Product
Ms Intas Pharmaceuticals Limited : Manufacturer and Marketing company
Ms Biodeal Pharmaceuticals Pvt. Ltd. : Manufacturer and Marketing company
Formoterol Fumarate Dihydrate IP : Pharmaceutical Product
Budesonide IP : Pharmaceutical Product
Ms Eris Healthcare Pvt. Ltd. : Manufacturer and Marketing company
Omeprazole IP : Pharmaceutical Product
Domperidone IP : Pharmaceutical Product
Ms Torrent Pharmaceuticals Limited : Manufacturer and Marketing company
Hydroxychloroquine Sulphate IP : Pharmaceutical Product
Beclomethasone Dipropionate IP : Pharmaceutical Product
Clotrimazole IP : Pharmaceutical Product
Escitalopram Oxalate IP : Pharmaceutical Product
Clonazepam IP : Pharmaceutical Product
See Full Document Text
रिज(cid:7021)(cid:7069)ी स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99
सी.जी.-डी.एल.-अ.-26112021-231406
xxxGIDHxxx
CG-DL-E-26112021-231406
xxxGIDExxx
असाधारण
EXTRAORDINARY
भाग II—ख(cid:7003) ड 3—उप-ख(cid:7003)ड (ii)
PART II—Section 3—Sub-section (ii)
(cid:7079)ािधकार स े(cid:7079)कािशत
PUBLISHED BY AUTHORITY
स.ं 4516] नई (cid:7408)द(cid:7016)ली शु(cid:7059)वार, नव(cid:7013)बर 26, 2021/अ(cid:7061)हायण 5, 1943
No. 4516] NEW DELHI, FRIDAY, NOVEMBER 26, 2021/AGRAHAYANA 5, 1943
रसायन और उव(cid:6981)रक मं(cid:7074)ालय
(औषध िवभाग)
(रा(cid:7398)ीय औषध म(cid:7016)ू य िनधा(cid:6981)रण (cid:7079)ािधकरण)
आदशे
नई (cid:7408)द(cid:7016)ली, 26 नव(cid:7013)बर, 2021
का.आ. 4884(अ).—भारत सरकार के रसायन और उव(cid:6981)रक मं(cid:7074)ालय (cid:7367)ारा जारी का.आ. 1394(अ) तारीख 30 मई, 2013
और का.आ. 701(अ) तारीख 10 माच(cid:6981), 2016 के साथ प(cid:7407)ठत औषध (क(cid:7409)मत िनय(cid:7074)ं ण) आदशे , 2013 के पैरा 5,11 और 15 (cid:7367)ारा (cid:7079)द(cid:7275)
शि(cid:7334)य(cid:7298) का (cid:7079)योग करते (cid:7263)ए, रा(cid:7398)ीय औषध म(cid:7016)ू य िनधा(cid:6981)रण (cid:7079)ािधकरण(िजसको संि(cid:6979)(cid:7385) (cid:7272)प म(cid:7286) एनपीपीए कहा जाता ह)ै नीचे क(cid:7409) सारणी
के (cid:7021)तंभ(6) म(cid:7286) िविन(cid:7416)द(cid:7397)(cid:6981) खुदरा मू(cid:7016)य को उ(cid:7334) सारणी के (cid:7021)तंभ (3), (4) और (5) म(cid:7286) त(cid:7004)(cid:7021)थानी (cid:7079)िवि(cid:7397)य(cid:7298) म(cid:7286) िविन(cid:7416)द(cid:7397)(cid:6981) (cid:7079)बलता, इकाई
(यूिनट) और िविनमा(cid:6981)ता और िवपणन कंपिनय(cid:7298) के नाम सिहत (cid:7021)तंभ(2) म(cid:7286) क(cid:7409) त(cid:7004)(cid:7021)थानी (cid:7079)िवि(cid:7397) म(cid:7286) स े(cid:7079)(cid:7004)येक क(cid:7409),व(cid:7021)तु एवं सेवा कर, य(cid:7408)द
कोई ह,ै को छोड़कर अिधकतम खुदरा मू(cid:7016)य के (cid:7272)प म(cid:7286) िनयत करती है
सारणी
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
1. टेि(cid:7016)मसट(cid:6981)न + (cid:7079)(cid:7004)येक अिलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) (cid:7410)वंडलास बायोटेक (cid:7079)ा. िलिमटेड / 16.27
टेि(cid:7016)मसट(cid:6981)न आईपी 80 िमली(cid:7061)ाम मसै स(cid:6981) मैनकाइंड फामा(cid:6981) िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन गोली
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम
2. से(cid:7408)फ(cid:6989)साइम गोली (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसै स(cid:6981) हेमा लबे ोरेटरीज (cid:7079)ा. िलिमटेड / 5.99
से(cid:7408)फ(cid:6989)साइम (cid:7069)ाइहाइ(cid:7071)टे आईपी अनहाइ(cid:7071)ौअस मसै स(cid:6981) सॉ(cid:7010)टडील फामा(cid:6981)(cid:7021)य(cid:7407)ूटक(cid:7016)स (cid:7079)ा.
6870 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
से(cid:7408)फ(cid:6989)साइम 100 िमली(cid:7061)ाम के बराबर िलिमटेड
3. टै(cid:7059)ोिलमस ओइं(cid:6999)म(cid:7286)ट 0.1% (cid:7079)(cid:7004)येक (cid:7061)ाम ओइं(cid:6999)म(cid:7286)ट म(cid:7286): 1 (cid:7061)ाम मसे स(cid:6981) हेिलओस फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स / मसे स(cid:6981) 35.44
ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य ू टै(cid:7059)ोिलमस आईपी 1 िमली(cid:7061)ाम पैनेिशया बायोटेक फामा(cid:6981) िलिमटेड
4. टै(cid:7059)ोिलमस ओइं(cid:6999)म(cid:7286)ट 0. (cid:7079)(cid:7004)येक (cid:7061)ाम ओइं(cid:6999)म(cid:7286)ट म(cid:7286): 1 (cid:7061)ाम मसे स(cid:6981) हेिलओस फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स / मसे स(cid:6981) 16.41
टै(cid:7059)ोिलमस आईपी 0.3 िमली(cid:7061)ाम पैनेिशया बायोटेक फामा(cid:6981) िलिमटेड
03% ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य ू
5. एटो(cid:7407)रकॉ(cid:6989)सीब + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) ए(cid:6989)म ेलाइफटेक एलएलपी। / 5.50
एटो(cid:7407)रकॉ(cid:6989)सीब आईपी 60 िमली(cid:7061)ाम मसै स(cid:6981) (cid:7069)ोइका फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
पैरािसटामोल गोली
पैरािसटामोल आईपी 325 िमली(cid:7061)ाम
6. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 10.88
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसे स(cid:6981) माइ(cid:7059)ो ल(cid:7011)ैस िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.5 िमली(cid:7061)ाम,
(cid:7407)रलीज़ ) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
7. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 12.91
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसे स(cid:6981) माइ(cid:7059)ो ल(cid:7011)ैस िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:7407)रलीज़) गोली
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.5 िमली(cid:7061)ाम,
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50
िमली(cid:7061)ाम के बराबर
8. कैि(cid:7016)शयम + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) यूएसवी (cid:7079)ाइवटे िलिमटेड 12.64
कैि(cid:7016)शयम (कैि(cid:7016)शयम हाइ(cid:7071)ॉ(cid:6989)साइड और कैि(cid:7016)शयम
कोलेकैि(cid:7016)सफेरॉल गोली
ऑ(cid:6989)साइड के (cid:7272)प म(cid:7286) हीटेड अलगई के साथ उपचा(cid:7407)रत)
500 िमली(cid:7061)ाम
कोलेकैि(cid:7016)सफेरॉल आईपी 2000 आईय,ू
9. िसि(cid:7016)निडिपन + टेि(cid:7016)मसट(cid:6981)न (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 11.61
+ (cid:6989)लोथा(cid:6981)िलडोन गोली िसि(cid:7016)निडिपन आईपी 10 िमली(cid:7061)ाम िलिमटेड / डॉ रे(cid:7355)ीज लबे ोरेटरीज
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम
10. पैरािसटामोल बाइलेयड(cid:6981) (cid:7079)(cid:7004)येक अन िलिपत बाइलेयड(cid:6981) गोली म:(cid:7286) 1 गोली मसै स(cid:6981) (cid:7021)ट(cid:7418)लग(cid:7304) लबै 2.90
गोली 1000 िमली(cid:7061)ाम पैरािसटामोल आईपी 300 िमली(cid:7061)ाम (इ(cid:7013)मीिडयेट
(cid:7407)रलीज के (cid:7272)प म(cid:7286))
पैरािसटामोल आईपी 700 िमली(cid:7061)ाम (स(cid:7021)ट(cid:7286)ड (cid:7407)रलीज
के (cid:7272)प म(cid:7286))
11. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 9.86
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) ए(cid:7407)रस लाइफसाइंसेज िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
12. ि(cid:6991)लमेपाइराइड + (cid:7079)(cid:7004)येक अन- िलिपत बाइलेयड(cid:6981) गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 9.41
मटे फो(cid:7414)म(cid:6981)न हाइ(cid:7071)ो(cid:6989)लोराइड ि(cid:6991)लमेपाइराइड आईपी 2 िमली(cid:7061)ाम, िलिमटेड / मसै स(cid:6981) ज.ेबी. केिमक(cid:7016)स एंड
फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
((cid:7079)ोल(cid:7298)(cid:6991)ड (cid:7407)रलीज फॉम(cid:6981)) मटे फो(cid:7414)म(cid:6981)न हाइ(cid:7071)ो(cid:6989)लोराइड आईपी 500 िमली(cid:7061)ाम
गोली ((cid:7079)ोल(cid:7298)(cid:6991)ड (cid:7407)रलीज फॉम(cid:6981) के (cid:7272)प म(cid:7286))
13. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) अक(cid:7013)स (cid:7071)(cid:6991)स एडं फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 8.92
+ अ(cid:7013)लोिडपाइन गोली टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, िलिमटेड / मसै स(cid:6981) मैनकाइंड फामा(cid:6981)
िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम
ए(cid:7013)लोिडपाइन बेिसलेट आईपी अ(cid:7013)लोिडपाइन 5
िमली(cid:7061)ाम के बराबर[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 3
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
14. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) अक(cid:7013)स (cid:7071)(cid:6991)स एडं फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 9.95
+ अ(cid:7013)लोिडपाइन गोली टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, िलिमटेड / मसै स(cid:6981) मैनकाइंड फामा(cid:6981)
िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम
ए(cid:7013)लोिडपाइन बेिसलेट आईपी अ(cid:7013)लोिडपाइन 5
िमली(cid:7061)ाम के बराबर
15. (cid:6989)लोथा(cid:6981)िलडोन + टेि(cid:7016)मसट(cid:6981)न (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) अक(cid:7013)स (cid:7071)(cid:6991)स एडं फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 8.60
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) माइ(cid:7059)ो ल(cid:7011)ैस िलिमटेड
गोली
टेि(cid:7016)मसट(cid:6981)न 40 िमली(cid:7061)ाम
16. मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) अजंता फामा(cid:6981) िलिमटेड 15.46
इवा(cid:7081)ाडीन गोली मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट आईपी 25 िमली(cid:7061)ाम
इवा(cid:7081)ाडीन हाइ(cid:7071)ो(cid:6989)लोराइड इवा(cid:7081)ाडीन 5 िमली(cid:7061)ाम
के बराबर
17. मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) अजंता फामा(cid:6981) िलिमटेड 17.74
इवा(cid:7081)ाडीन गोली मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट आईपी 50 िमली(cid:7061)ाम
इवा(cid:7081)ाडीन हाइ(cid:7071)ो(cid:6989)लोराइड इवा(cid:7081)ाडीन 5 िमली(cid:7061)ाम
के बराबर
18. िल(cid:7336)ोकेन हाइ(cid:7071)ो(cid:6989)लोराइड जेल म:(cid:7286) 1 (cid:7061)ाम मसे स(cid:6981) (cid:6989)योरटेक ि(cid:7021)कनकेयर / मसे स(cid:6981) 3.48
+ (cid:6989)लोरहेि(cid:6989)सिडन (cid:6991)लकू ोनेट िल(cid:7336)ोकेन हाइ(cid:7071)ो(cid:6989)लोराइड आईपी 2.0% ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य,ू ज.ेबी.केिमक(cid:7016)स एंड फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स
+ म(cid:7069)े ोिनडाजोल जले िलिमटेड
(cid:6989)लोरहेि(cid:6989)सिडन (cid:6991)लूकोनेट आईपी 1% ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य,ू
म(cid:7069)े ोिनडाजोल 1% आईपी ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य ू
19. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 10.88
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) ए(cid:7407)रस लाइफसाइंसेज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
20. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 10.81
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) ए(cid:7407)रस लाइफसाइंसेज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.5 िमली(cid:7061)ाम मेटो(cid:7079)ोलोल
टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50 िमली(cid:7061)ाम के
बराबर
21. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 12.91
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) ए(cid:7407)रस लाइफसाइंसेज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.5 िमली(cid:7061)ाम मेटो(cid:7079)ोलोल
टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50 िमली(cid:7061)ाम के
बराबर
22. एज़ेलिनडाइिपन + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) अक(cid:7013)स (cid:7071)(cid:6991)स एडं फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 11.37
एज़ेलिनडाइिपन आईपी 8 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) इ(cid:7009)का लबे ोरेटरीज
टेि(cid:7016)मसट(cid:6981)न गोली
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड
23. एज़ेलिनडाइिपन + (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) अक(cid:7013)स (cid:7071)(cid:6991)स एडं फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 13.27
टेि(cid:7016)मसट(cid:6981)न गोली
एज़ेलिनडाइिपन आईपी 8 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) इ(cid:7009)का लबे ोरेटरीज
टेि(cid:7016)मसट(cid:6981)न आईपी 80 िमली(cid:7061)ाम िलिमटेड
24. रोसुवा(cid:7021)टे(cid:7407)टन + (cid:7079)(cid:7004)येक हाड(cid:6981) िजले(cid:7407)टन कै(cid:7009)सलू म:(cid:7286) 1 कै(cid:7009)सलू मसे स(cid:6981) िसनोकेम फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 19.64
(cid:6989)लोिपडो(cid:7061)ले कै(cid:7009)सलू रोसुवा(cid:7021)टे(cid:7407)टन कैि(cid:7016)शयम आईपी रोसुवा(cid:7021)टे(cid:7407)टन 20 िलिमटेड / मसे स(cid:6981) कैिडला
फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
िमली(cid:7061)ाम (पेल(cid:6999)ै स के (cid:7272)प म(cid:7286)) के बराबर
(cid:6989)लोिपडो(cid:7061)ले िबस(cid:7016)फेट आईपी (cid:6989)लोिपडो(cid:7061)ले 75
िमली(cid:7061)ाम (पेल(cid:6999)ै स के (cid:7272)प म(cid:7286)) के बराबर4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
25. रोसुवा(cid:7021)टे(cid:7407)टन + एि(cid:7021)प(cid:7407)रन (cid:7079)(cid:7004)येक हाड(cid:6981) िजले(cid:7407)टन कै(cid:7009)सलू म:(cid:7286) 1 कै(cid:7009)सलू मसे स(cid:6981) िसनोकेम फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स 5.99
कै(cid:7009)सलू रोसुवा(cid:7021)टे(cid:7407)टन कैि(cid:7016)शयम आईपी रोसुवा(cid:7021)टे(cid:7407)टन 10 िलिमटेड / मसे स(cid:6981) कैिडला
फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
िमली(cid:7061)ाम (पेल(cid:6999)ै स के (cid:7272)प म(cid:7286)) के बराबर
एि(cid:7021)प(cid:7407)रन आईपी 75 िमली(cid:7061)ाम (एंटे(cid:7407)रक िलिपत गोली
के (cid:7272)प म(cid:7286))
26. टेि(cid:7016)मसट(cid:6981)न + अ(cid:7013)लोिडपाइन (cid:7079)(cid:7004)येक अिलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 9.51
गोली टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) जबे ी केिमक(cid:7016)स एंड
फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
अ(cid:7013)लोिडपाइन बेिसलेट आईपी अ(cid:7013)लोिडपाइन 5
िमली(cid:7061)ाम के बराबर
27. टेि(cid:7016)मसट(cid:6981)न + िसि(cid:7016)निडिपन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 10.68
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) जबे ी केिमक(cid:7016)स एंड
+ मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट
िसि(cid:7016)निडिपन आईपी 10 िमली(cid:7061)ाम फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
(ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
28. टेि(cid:7016)मसट(cid:6981)न + िसि(cid:7016)निडिपन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 12.95
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड / मसे स(cid:6981) जबे ी केिमक(cid:7016)स एंड
+ मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट
िसि(cid:7016)निडिपन आईपी 10 िमली(cid:7061)ाम फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
(ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50िमली(cid:7061)ाम मेटो(cid:7079)ोलोल
टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50 िमली(cid:7061)ाम के
बराबर
29. ि(cid:6991)लमेपाइराइड + (cid:7079)(cid:7004)येक अिलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 6.72
ि(cid:6991)लमेपाइराइड आईपी 1 िमली(cid:7061)ाम, िलिमटेड / मसे स(cid:6981) जबे ी केिमक(cid:7016)स एंड
मटे फो(cid:7414)म(cid:6981)न हाइ(cid:7071)ो(cid:6989)लोराइड
फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
मटे फो(cid:7414)म(cid:6981)न हाइ(cid:7071)ो(cid:6989)लोराइड आईपी 500 िमली(cid:7061)ाम
((cid:7079)ोल(cid:7298)(cid:6991)ड (cid:7407)रलीज के (cid:7272)प म)(cid:7286) ((cid:7079)ोल(cid:7298)(cid:6991)ड (cid:7407)रलीज के (cid:7272)प म(cid:7286))
गोली
30. एटोरवा(cid:7021)टे(cid:7407)टन + एि(cid:7021)प(cid:7407)रन (cid:7079)(cid:7004)येक हाड(cid:6981) िजले(cid:7407)टन कै(cid:7009)सलू म:(cid:7286) 1 कै(cid:7009)सलू मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 2.68
एटोरवा(cid:7021)टे(cid:7407)टन कैि(cid:7016)शयम आईपी एटोरवा(cid:7021)टे(cid:7407)टन 10 िलिमटेड / मसे स(cid:6981) जबे ी केिमक(cid:7016)स एंड
कै(cid:7009)सलू
िमली(cid:7061)ाम ((cid:7408)फ(cid:7016)म िलिपत गोली के (cid:7272)प म(cid:7286)) के बराबर फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
एि(cid:7021)प(cid:7407)रन आईपी 75 िमली(cid:7061)ाम (एंटे(cid:7407)रक िलिपत गोली
के (cid:7272)प म(cid:7286))
31. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा। िलिमटेड/ 9.86
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) इ(cid:7009)का लेबोरेटरीज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:7407)रलीज़) गोली
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम,
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
32. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा। िलिमटेड/ 10.88
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) इ(cid:7009)का लेबोरेटरीज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
33. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा। िलिमटेड/ 10.81
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) इ(cid:7009)का लेबोरेटरीज िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 6.25 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50
िमली(cid:7061)ाम के बराबर
34. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा। िलिमटेड/ 12.91[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 5
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) इ(cid:7009)का लेबोरेटरीज िलिमटेड
(cid:7407)रलीज़) गोली (cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50
िमली(cid:7061)ाम के बराबर
35. एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) (cid:7410)वंडलास बायोटेक िलिमटेड / 7.81
+ (cid:6989)लोनाज़ेपम गोली एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे आईपी एि(cid:7021)सटालो(cid:7079)ाम 5 मसे स(cid:6981) मैनकाइंड फामा(cid:6981) िलिमटेड
िमली(cid:7061)ाम के बराबर,
(cid:6989)लोनाज़ेपम आईपी 0.5 िमली(cid:7061)ाम
36. एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) (cid:7410)वंडलास बायोटेक िलिमटेड / 9.56
+ (cid:6989)लोनाज़ेपम गोली एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे आईपी एि(cid:7021)सटालो(cid:7079)ाम 10 मसे स(cid:6981) मैनकाइंड फामा(cid:6981) िलिमटेड
िमली(cid:7061)ाम के बराबर,
(cid:6989)लोनाज़ेपम आईपी 0.25 िमली(cid:7061)ाम
37. एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) माइ(cid:7059)ो ल(cid:7011)ैस िलिमटेड 19.92
+ (cid:6989)लोनाज़ेपम गोली एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे आईपी एि(cid:7021)सटालो(cid:7079)ाम 20
िमली(cid:7061)ाम के बराबर,
(cid:6989)लोनाज़ेपम आईपी 0.5 िमली(cid:7061)ाम
38. एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) माइ(cid:7059)ो ल(cid:7011)ैस िलिमटेड 7.90
+ (cid:6989)लोनाज़ेपम गोली एि(cid:7021)सटालो(cid:7079)ाम ऑ(cid:6989)सालटे आईपी एि(cid:7021)सटालो(cid:7079)ाम 5
िमली(cid:7061)ाम के बराबर,
(cid:6989)लोनाज़ेपम आईपी 0.5 िमली(cid:7061)ाम
39. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड 12.91
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, / मसै स(cid:6981) इंटास फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:7407)रलीज़) गोली
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50
िमली(cid:7061)ाम के बराबर
40. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 10.88
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसै स(cid:6981) इंटास फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
41. िसि(cid:7016)निडिपन + टेि(cid:7016)मसट(cid:6981)न (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म (cid:7408)फ(cid:7016)म- िलिपत गोली म(cid:7286): 1 गोली मसै स(cid:6981) (cid:7009)योर एंड (cid:6989)योर हे(cid:7016)थकेयर (cid:7079)ा. 12.946
िसि(cid:7016)निडिपन आईपी 10 िमली(cid:7061)ाम िलिमटेड / डॉ रे(cid:7355)ीज लबे ोरेटरीज
+
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम िलिमटेड
(cid:6989)लोथा(cid:6981)िलडोन गोली
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.5 िमली(cid:7061)ाम
42. फॉम(cid:7299)टेरोल (cid:7010)यूमरेट + (cid:7079)(cid:7004)यके हाड(cid:6981) िजले(cid:7407)टन कै(cid:7009)सलू म:(cid:7286) 1 कै(cid:7009)सलू मसे स(cid:6981) बायोडील फामा(cid:6981)(cid:7021)य(cid:7407)ूटक(cid:7016)स (cid:7079)ा. 7.10
फॉम(cid:7299)टेरोल (cid:7010)यूमरेट डाइहाइ(cid:7071)टे आईपी फॉम(cid:7299)टेरोल िलिमटेड / मसे स(cid:6981) मैनकाइंड फामा(cid:6981)
बुडेसोनाइड इ(cid:7008)हेलेसन के
िलये पाउडर (cid:7010)यूमरेट 12 एमसीजी के बराबर िलिमटेड
बुडेसोनाइड आईपी 400 एमसीजी
43. ओम(cid:7079)े ाज़ोल (िडलाईड (cid:7079)(cid:7004)येक हाड(cid:6981) िजले(cid:7407)टन कै(cid:7009)सलू म:(cid:7286) 1 कै(cid:7009)सलू मसे स(cid:6981) ए(cid:7407)रस लाइफसाइंसेज िलिमटेड / 8.53
ओम(cid:7079)े ाज़ोल आईपी 20 िमली(cid:7061)ाम (एटं (cid:7407)रक लेिपत मसे स(cid:6981) ए(cid:7407)रस हे(cid:7016)थकेयर (cid:7079)ा. िलिमटेड
(cid:7407)रलीज) + डोमप(cid:7407)रडोन
पैलटे के (cid:7272)प म(cid:7286))
(स(cid:7021)ट(cid:7286)ड (cid:7407)रलीज) कै(cid:7009)सूल डोमप(cid:7407)रडोन आईपी 30 िमली(cid:7061)ाम (स(cid:7021)ट(cid:7286)ड (cid:7407)रलीज
पैलटे के (cid:7272)प म(cid:7286))
44. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 12.916 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
(cid:7059)ं स ं िविन(cid:7414)मि(cid:6981)त का नाम/(cid:7081)ाडं का (cid:7079)बलता इकाई िविनमात(cid:6981) ा और िवपणन कंपनी खदु रा
नाम म(cid:7016)ू य ((cid:7272).)
(1) (2) (3) (4) (5) (6)
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसे स(cid:6981) टोर(cid:7286)ट फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
(cid:7407)रलीज़) गोली (cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 47.50 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 50
िमली(cid:7061)ाम के बराबर
45. टेि(cid:7016)मसट(cid:6981)न + (cid:6989)लोथा(cid:6981)िलडोन (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म- िलिपत बाइलेयड (cid:6981)गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले ह(cid:7016)े थकेयर (cid:7079)ा. िलिमटेड/ 10.88
टेि(cid:7016)मसट(cid:6981)न आईपी 40 िमली(cid:7061)ाम, मसे स(cid:6981) टोर(cid:7286)ट फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
+ मटे ो(cid:7079)ोलोल (ए(cid:6989)सटे(cid:7008)डेड
(cid:6989)लोथा(cid:6981)िलडोन आईपी 12.50 िमली(cid:7061)ाम,
(cid:7407)रलीज़) गोली
मटे ो(cid:7079)ोलोल सि(cid:6989)सनेट IP 23.75 िमली(cid:7061)ाम
मटे ो(cid:7079)ोलोल टा(cid:7069)(cid:7287)ट (ए(cid:6989)सटे(cid:7008)डेड (cid:7407)रलीज़ के (cid:7272)प म(cid:7286)) 25
िमली(cid:7061)ाम के बराबर
46. हाइ(cid:7071)ो(cid:6989)सी(cid:6989)लोरो(cid:7332)(cid:7409)न गोली (cid:7079)(cid:7004)येक (cid:7408)फ(cid:7016)म िलिपत गोली म(cid:7286): 1 गोली मसे स(cid:6981) रेवेनभले बायोटेक / मसे स(cid:6981) टोर(cid:7286)ट 12.55
हाइ(cid:7071)ो(cid:6989)सी(cid:6989)लोरो(cid:7332)(cid:7409)न स(cid:7016)फेट आईपी 300 िमली(cid:7061)ाम फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स िलिमटेड
47. ब(cid:6989)े लोमथे ासोन (cid:7061)ाम म(cid:7286): 1 (cid:7061)ाम मसे स(cid:6981) (cid:6989)योरटेक ि(cid:7021)कनकेयर / मसे स(cid:6981) 5.20
िड(cid:7079)ोिपयोनेट + ब(cid:6989)े लोमथे ासोन िड(cid:7079)ोिपयोनेट आईपी 0.025% ज.ेबी. केिमक(cid:7016)स एंड फामा(cid:6981)(cid:7021)य(cid:7407)ुटक(cid:7016)स
(cid:6989)लो(cid:7407)(cid:7069)मज़े ोल (cid:7059)(cid:7409)म ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य,ू िलिमटेड
(cid:6989)लो(cid:7407)(cid:7069)मज़े ोल आईपी 1.0% ड(cid:7011)(cid:7016)य/ूड(cid:7011)(cid:7016)य,ू
uksV %
¼d½ mi;qZDr nh xbZ fofufnZ"V QkWewZys'ku ds fofuekrZ k vFkkZr tks ÞubZ Mªxß Mhihlhvks] 2013 ds iSjkxkzQ 2¼;w½ ds rgr mi;qZDr nh xbZ lkj.kh ds
LraHk ¼6½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA
¼[k½ vxj fuekZrkvksa us mi;qZD`r lkj.kh ds LraHk (6) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os oLrq
,oa lsok dj dks tksM+ ldrs gSaA
¼x½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxkzQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼6½ esa fofufnZ"V [kqnjk
ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxkzQ 24 ds
rgr QkWeZ V esa vf/klwpuk dh rkjh[k ls ,d ewY; lwph ,uihih, dks vkbZihMh,e,l ds ek/;e ls tkjh djsa rFkk mldh dkiWh jkT; vkS"kf/k
fu;a=dksa vkSj fofuekZrk forjdksa dks tkjh djsaA
¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds 24 (4) ds mica/kksa ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk }kjk fn, x, :i esa ,sls
ifjlj] tgka dkjckj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds fy, igqap vklku gks] ogka mlds fdlh lgtn`’;
Hkkx ij dher lwph vkSj iwjd lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA
¼M-½ mi;qZDr xSj vf/kdre dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013
ds rgr vuqc) ewY; fu/kkZj.k@la'kks/ku ds fy, QkWe ZI ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkZfjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ
ds v/khu izklafxd fof/k;ksa@fu;eksa ds vUrxZr tSlk fd dsUnzh;@jkT; ykblsflax vkWFkksfjVh ds l{ke izkf/kdkjh }kjk esU;wQsDpfjax ykblsal eatwjh ds
rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA
¼p½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ksa vkSj fofufnZ"V 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk
ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA
¼N½ bl vkns'k eas mijksDr lkj.kh ds LraHk ¼2½ eas dh rRLFkkuh izfof"V ea s fofufnZ"V fofufeZfr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kkeLo#i]
vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxAs
[पीएन/225/93/2021/एफ/फा.न.8(93)/2021/डी.पी./एनपीपीए-डी.वी.-II]
izlsuthr nkl] उप िनदेशक[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 7
MINISTRY OF CHEMICALS AND FERTILIZERS
(Department of Pharmaceuticals)
(NATIONAL PHARMACEUTICAL PRICING AUTHORITY)
ORDER
New Delhi, the 26th November, 2021
S.O. 4884(E).—In exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs
(Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th
March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National
Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in
column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in
relation to the formulation specified in the corresponding entry in column (2) of the said Table with the
strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in
columns (3), (4) and (5) thereof;
TABLE
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Company Price
Brand Name (Rs.)
(1) (2) (3) (4) (5) (6)
1. Telmisartan + Each uncoated bilayered tablet 1 Tablet M/s Windlas Biotech Pvt. 16.27
Chlorthalidone contains: Ltd. /M/s Mankind
Tablet Telmisartan IP 80.mg Pharma Ltd.
Chlorthalidone IP 6.25mg
2. Cefixime Tablets Each film coated tablet contains: 1 Tablet M/s. Hema Laboratories 5.99
Cefixime IP as Trihydrate eq. to Pvt. Ltd. / M/s Softdeal
Anhydrous Cefixime 100mg Pharmaceuticals Pvt. Ltd.
3. Tacrolimus Each gm of Ointment contains: 1 gram M/s Helios 35.44
Ointment 0.1% w/w Tacrolimus IP 1mg Pharmaceuticals / M/s
Panacea Biotec Pharma
Limited
4. Tacrolimus Each gm of Ointment contains: 1 gram M/s Helios 16.41
Ointment 0.03% Tacrolimus IP 0.3mg Pharmaceuticals / M/s
w/w Panacea Biotec
PharmaLimited
5. Etoricoxib + Each film coated tablet contains 1 T a b le t M / s A cme Lifetech LLP. / 5.50
Paracetamol Tablet Etoricoxib IP 60 mg M/s Troikaa
Paracetamol IP 325 mg Pharmaceuticals Ltd.
6. Telmisartan + Each film-coated bilayered tablet 1 Tablet M/s Ravenbhel 10.88
Chlorthalidone + contains: Healthcare Pvt. Ltd. / M/s
Metoprolol (As Telmisartan IP 40mg, Micro Labs Ltd.
Extended release Chlorthalidone IP 12.5mg,
form) Tablet Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as Extended
release) 25mg
7. Telmisartan + Each film-coated bilayered tablet 1 Tablet M/s Ravenbhel 12.91
Chlorthalidone + contains: Healthcare Pvt. Ltd. / M/s
Metoprolol (As Telmisartan IP 40mg, Micro Labs Ltd.
Extended release Chlorthalidone IP 12.5mg,
form) Tablet Metoprolol Succinate IP 47.50mg eq.
to Metoprolol Tartrate (as Extended
release) 50mg
8. Calcium + Each film-coated tablet contains: 1 Tablets M/s USV Private Limited. 12.64
Cholecalciferol Calcium (In the form of Calcium
Tablets hydroxide and Calcium oxide
pretreated with heated algae) 500mg
Cholecalciferol IP 2000IU,8 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Company Price
Brand Name (Rs.)
(1) (2) (3) (4) (5) (6)
9. Cilnidipine, Each Film Coated Tablet contains: 1 Tablet M/s Pure and Cure 11.61
Telmisartan & Cilnidipine IP 10mg Healthcare Pvt. Ltd. / M/s
Chlorthalidone Telmisartan IP 40mg Dr. Reddy's Laboratories
Tablets Chlorthalidone IP 6.25mg Ltd.
10. Paracetamol Each uncoated bilayered tablet 1 Tablet M/s. Sterling Lab 2.90
bilayered Tablet contains:
1000mg Paracetamol IP 300mg (as Immediate
release)
Paracetamol IP 700mg (as sustained
release)
11. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 9.86
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Eris Lifesciences Limited
Tablet Chlorthalidone IP 6.25mg
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg
12. Glimepiride + Each uncoated bilayered tablet 1 Tablet M/s Pure & Cure 9.41
Metformin contains: Healthcare Pvt. Ltd. /M/s
Hydrochloride (as Glimepiride IP 2mg, J. B. Chemicals &
Prolonged release Metformin Hydrochloride IP 500mg Pharmcaeuticals Ltd.
form) Tablet (as Prolonged release form)
13. Telmisartan, Each film coated tablet contains: 1 Tablet M/s Akums Drugs & 8.92
Chlorthalidone & Telmisartan IP 40mg, Pharmaceuticals Ltd.
Amlodipine Tablet Chlorthalidone IP 6.25mg /M/s Mankind Pharma
Amlodipine Besylate IP eq. to Ltd.
Amlodipine 5mg
14. Telmisartan, Each film coated tablet contains: 1 Tablet M/s Akums Drugs & 9.95
Chlorthalidone & Telmisartan IP 40mg, Pharmaceuticals Ltd.
Amlodipine Tablet Chlorthalidone IP 12.50mg /M/s Mankind Pharma
Amlodipine Besylate IP eq. to Ltd.
Amlodipine 5mg
15. Chlorthalidone + Each film coated Tablet contains: 1 Tablet M/s Akums Drugs & 8.60
Telmisartan Tablet Chlorthalidone IP 6.25mg Pharmaceuticals Ltd. /
Telmisartan 40mg M/s Micro Labs Limited
16. Metoprolol Tartrate Each film coated tablet contains: 1 Tablet M/s. Ajanta Pharma 15.46
+ Ivabradine Tablet Metoprolol Tartrate IP 25mg Limited
Ivabradine Hydrochloride eq. to
Ivabradine 5mg
17. Metoprolol Tartrate Each film coated tablet contains: 1 Tablet M/s. Ajanta Pharma 17.74
+ Ivabradine Tablet Metoprolol Tartrate IP 50mg Limited
Ivabradine Hydrochloride eq. to
Ivabradine 5mg
18. Lignocaine Gel contains: 1 Gram M/s Curetech Skincare / 3.48
Hydrochloride, Lignocaine Hydrochloride IP M/s J.B.Chemicals &
Chlorhexidine 2.0%w/w, Pharmaceuticals Ltd.
Gluconate & Chlorhexidine Gluconate IP 1% w/w,
Metronnidazole Gel Metronnidazole 1% IP w/w
19. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.88
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Eris Lifesciences Limited
Tablet Chlorthalidone IP 12.50mg
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 9
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Company Price
Brand Name (Rs.)
(1) (2) (3) (4) (5) (6)
20. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.81
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Eris Lifesciences Limited
Tablet Chlorthalidone IP 6.25mg
Metoprolol Succinate IP 47.5mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
21. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 12.91
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Eris Lifesciences Limited
Tablet Chlorthalidone IP 12.50mg
Metoprolol Succinate IP 47.5mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
22. Azelnidipine + Each film coated bi-layered tablet 1 Tablet M/s Akums Drugs & 11.37
Telmisartan Tablet contains: Pharmaceuticals Ltd. /
Azelnidipine IP 8mg M/s Ipca Laboratories
Telmisartan IP 40mg Limited
23. Azelnidipine + Each film coated bi-layered tablet 1 Tablet M/s Akums Drugs & 13.27
Telmisartan Tablet contains: Pharmaceuticals Ltd. /
Azelnidipine IP 8mg M/s Ipca Laboratories
Telmisartan IP 80mg Limited
24. Rosuvastatin + Each hard gelatin capsule contains: 1 M/s Synokem 19.64
Clopidogrel Rosuvastatin Calcium IP eq. to Capsule Pharmaceuticals Ltd. /
Capsule Rosuvastatin 20mg (As Pellets) Cadila Pharmaceuticals
Clopidogrel Bisulphate IP eq. to Ltd.
Clopidogrel 75mg (As Pellets)
25. Rosuvastatin + Each hard gelatin capsule contains: 1 M/s Synokem 5.99
Aspirin Capsule Rosuvastatin Calcium IP eq. to Capsule Pharmaceuticals Ltd. /
Rosuvastatin 10mg (As Pellets) Cadila Pharmaceuticals
Aspirin IP 75mg (As enteric coated Ltd.
Pellets)
26. Telmisartan + Each Uncoated bilayered Tablet 1 Tablet M/s Pure and Cure 9.51
Amlodipine Tablet Contains: Healthcare Pvt. Ltd. / M/s
Telmisartan IP 40mg J.B.Chemicals &
Amlodipine Besilate IP eq. Pharmaceuticals Ltd.
Amlodipine 5mg
27. Telmisartan + Each film coated tablet contains: 1 Tablet M/s Pure and Cure 10.68
Cilnidipine + Telmisartan IP 40mg Healthcare Pvt. Ltd. / M/s
Metoprolol Cilnidipine IP 10mg J.B.Chemicals &
Succinate (ER) Metoprolol Succinate IP 23.75mg eq. Pharmaceuticals Ltd.
Tablet to Metoprolol Tartarate 25 mg (as
Extended Release form)
28. Telmisartan + Each film coated tablet contains: 1 Tablet M/s Pure and Cure 12.95
Cilnidipine + Telmisartan IP 40mg Healthcare Pvt. Ltd. / M/s
Metoprolol Cilnidipine IP 10mg J.B.Chemicals &
Succinate (ER) Metoprolol Succinate IP 47.50mg eq. Pharmaceuticals Ltd.
Tablet to Metoprolol Tartarate 50 mg (as
Extended Release form)
29. Glimepiride + Each uncoated bilayered tablet 1 Tablet M/s Pure & Cure 6.72
Metformin contains: Healthcare Pvt. Ltd. /M/s
Hydrochloride (as Glimepiride IP 1mg, J. B. Chemicals &
Prolonged release Metformin Hydrochloride IP 500mg Pharmcaeuticals Ltd.
form) Tablet (as Prolonged release form)
30. Atorvastatin + Each hard Gelatin Capsule contains: 1 M/s Pure & Cure 2.68
Aspirin Capsule Atorvastatin Calcium IP eq. to Capsule Healthcare Pvt. Ltd. /M/s
Atorvastatin 10mg (As Film Coated J. B. Chemicals &10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Company Price
Brand Name (Rs.)
(1) (2) (3) (4) (5) (6)
Tablet Form) Pharmcaeuticals Ltd.
Aspirin IP 75mg (As Enteric Coated
Tablet Form)
31. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 9.86
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, IPCA Laboratories
Tablet Chlorthalidone IP 6.25mg Limited
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg
32. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.88
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, IPCA Laboratories
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg
33. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.81
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, IPCA Laboratories
Tablet Chlorthalidone IP 6.25mg Limited
Metoprolol Succinate IP 47.50mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
34. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 12.91
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, IPCA Laboratories
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 47.50mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
35. Escitalopram Each film coated tablet contains: 1 Tablet M/s Windlas Biotech 7.81
Oxalate + Escitalopram Oxalate IP eq. to Limited / M/s Mankind
Clonazepam Tablet Escitalopram 5mg, Pharma Ltd.
Clonazepam IP 0.5mg
36. Escitalopram Each film coated tablet contains: 1 Tablet M/s Windlas Biotech 9.56
Oxalate + Escitalopram Oxalate IP eq. to Limited / M/s Mankind
Clonazepam Tablet Escitalopram 10mg, Pharma Ltd.
Clonazepam IP 0.25mg
37. Escitalopram Each film coated tablet contains: 1 Tablet M/s Micro Labs Limited 19.92
Oxalate + Escitalopram Oxalate IP eq. to
Clonazepam Tablet Escitalopram 20mg
Clonazepam IP 0.5mg
38. Escitalopram Each film coated tablet contains: 1 Tablet M/s Micro Labs Limited 7.90
Oxalate + Escitalopram Oxalate IP eq. to
Clonazepam Tablet Escitalopram 5mg
Clonazepam IP 0.5mg
39. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 12.91
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Intas Pharmaceuticals
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 47.50mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
40. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.88
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Intas Pharmaceuticals[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 11
Sl. Name of the Strength Unit Manufacturer & Retail
No. Formulation / Marketing Company Price
Brand Name (Rs.)
(1) (2) (3) (4) (5) (6)
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg
41. Cilnidipine, Each Film Coated Tablet contains: 1 Tablet M/s Pure and Cure 12.946
Telmisartan & Cilnidipine IP 10mg Healthcare Pvt. Ltd. / Dr.
Chlorthalidone Telmisartan IP 40mg Reddy's Laboratories Ltd.
Tablets Chlorthalidone IP 12.5mg
42. Formoterol Each hard gelatin capsule contains: 1 M/s Biodeal 7.10
Fumarate + Formoterol Fumarate Dihydrate IP Capsule Pharmaceuticals Pvt.
Budesonide eq. to Formoterol Fumarate 12mcg Ltd./ M/s Mankind
Powder for Budesonide IP 400mcg Pharma Limited
Inhalation
43. Omeprazole Each hard gelatin capsule contains: 1 M/s. Eris Lifesciences 8.53
(Delayed-Release) Omeprazole IP 20mg (as enteric Capsule Ltd. / M/s Eris Healthcare
+ Domperidone coated pallets) Pvt. Ltd.
(Sustained Domperidone IP 30mg (as sustained
Release) Capsule release pallets)
44. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 12.91
Chlorthalidone & contains: Healthcare Pvt. Ltd. /M/s
Metoprolol (ER) Telmisartan IP 40mg, Torrent Pharmaceuticals
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 47.50mg eq.
to Metoprolol Tartrate (as extended
release) 50mg
45. Telmisartan, Each film coated bilayered tablet 1 Tablet M/s Ravenbhel 10.88
Chlorthalidone & contains: Healthcare Pvt. Ltd. / M/s
Metoprolol (ER) Telmisartan IP 40mg, Torrent Pharmaceuticals
Tablet Chlorthalidone IP 12.50mg Limited
Metoprolol Succinate IP 23.75mg eq.
to Metoprolol Tartrate (as extended
release) 25mg
46. Hydroxychloroquine Each film coated tablet contains: 1 Tablet M/s Ravenbhel Biotech 12.55
Tablet Hydroxychloroquine Sulphate IP 300 /M/s Torrent
mg Pharmaceuticals Limited
47. Beclomethasone Gram Contains: 1 Gram M/s Curetech Skincare / 5.20
Dipropionate + Beclomethasone Dipropionate IP M/s J. B. Chemicals &
Clotrimazole Cream 0.025% w/w, Pharmaceuticals Ltd.
base Clotrimazole IP 1.0%w/w,
Note:
(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the
DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable
to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned
manufacturer in accordance with the retail price specified in column (6) of the above table as per
provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list
in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through
IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the
supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the12 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
premises where he carries on business in a manner so as to be easily accessible to any person
wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as
mentioned above i.e. who have applied for the same by submitting Form-I for price fixation /
revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory
requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing
license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may
be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price
notification and notes specified hereinabove, then the concerned manufacturer/marketing company
shall be liable to deposit the overcharged amount along with the interest thereon under the
provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above
table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the
above said date of notification, stand(s) superseded.
[PN/225/93/2021/F/F. No. 8(93)/2021/D.P./NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
आदशे
नई (cid:7408)द(cid:7016)ली, 26 नव(cid:7013)बर, 2021
का.आ. 4885(अ).—भारत सरकार के jlk;u vkSj moZjd ea=ky; }kjk tkjh dk0 vk0 1394¼v½ rkjh[k 30 ebZ]
2013 vkSj dk0 vk0 701¼v½ rkjh[k 10 ekpZ] 2016 ds lkFk ifBr vkS"k/k ¼dher fu;=a .k½ vkns'k] 2013 ds iSjk 4, 6, 10,
11, 14, 16, 17 vkSj 18 }kjk iznRr 'kfDr;ka s dk iz;ksx djrs gq,] jk”Vªh; vkS”k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftls laf{kIr
:i ls ,uihih, dgk tkrk gS½ uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ”V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½
vkSj ¼4½ esa Øe’k% rRLFkkuh izfof”V;ksa esa fofufnZ”V [kqjkd :i ,oa izcyrk vkSj bdkbZ lfgr ml lkj.kh ds LrHa k ¼2½ esa dh
rRLFkkuh izfof”V esa fofufnZ”V vuqlwfpr fofufeZfr;ksa esa ls izR;ds dh] oLrq ,o a lsok dj] ;fn dksbZ gS] dks NkMs +dj
vf/kdre dher ds :i esa fu;r djrh gS%
lkj.kh
dz-la- vuqlwfpr fofufefZr dk uke [kqjkd :i ,oa izcyrk bdkbZ vf/kdre
dher ¼#-½
(1) (2) (3) (4) (5)
1. िमथाइलिथओिनिनयम इंजे(cid:6989)शन 10 िमली(cid:7061)ाम/िम.ली. 1 िम.ली. 21.85
(cid:6989)लोराइड (मेिथलीन (cid:7011)लू )
2. हाइ(cid:7071)ो(cid:6989)सोकोबालािमन इंजे(cid:6989)शन 1 िमली(cid:7061)ाम/एमएल 1 िम.ली. 9.91
¼d½ ljdkj }kjk bl izdkj fu;r dh xbZ vkSj vf/klwfpr dh xbZ vf/kdre dher ¼/ku oLr q ,oa lsok dj] tk s ykxw gksa½ ls
vf/kd dher ij vuqlwfpr fofufeZfr;ksa ds czkMa sM ;k tsusfjd ;k nksuksa :ikarjksa dks csp jg s vuqlwfpr fofufeZfr;ka s ds lHkh
fofuekZrk] mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ¼/ku oLrq ,oa lsok dj] tks ykxw gka½s ls vf/kd lHkh ,slh
fofufeZr;ksa dh dher dk v/kkseq[kh iqujh{k.k djaxs sA
¼[k½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;ZqDr lkj.kh ds LraHk
¼5½ esa fofufnZ"V vf/kdre dher oLrq ,o a lsok dj lfgr ls de gS rks] tgk a dgh Hkh ykx w gks] vkS"k/k ¼ewY; fu;a=.k½
vkns'k] 2013 ds iSjkxzkQ 13(2) ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA
¼x½ vxj fuekZrkvksa u s mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k
;g n;s gS rks o s oLrq ,oa lsok dj dks tksM+ ldr s gSaA[भाग II—ख(cid:7003) ड 3(ii)] भारत का राजप(cid:7074) : असाधारण 13
¼?k½ vkS"k/k ¼ewY; fu;a=.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr lEcfU/kr fuekZrkvksa dks mi;qZDr
lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher
fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;=a .k½ vkns'k] 2013 ds iSjkxzkQ 24 ds rgr QkWeZ&V esa vf/klwpuk dh rkjh[k ls
vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dk s ,d ewY; lwph tkjh djsa rFkk mldh dkWih jkT; vkS"k/kh fu;=a dksa vkSj
fofuekZrk forjdksa dks tkjh djsaA
¼M+½ vkS"k/k ¼ewY; fu;=a .k½ vkns'k] 2013 ds iSjk 24 ¼4½ ds mica/kka s ds vuqlkj izR;sd QqVdj fodzsrk vkSj forjd fofuekZrk
}kjk fn, x, :i esa ,sls ifjlj] tgka dkjkcs kj dks bl izdkj fd;k tk jgk gS fd mlls ijke’kZ ds bPNqd fdlh O;fDr ds
fy, igqap vklku gks] ogka mlds fdlh lgtn`'; Hkkx ij dher lwph vkSj ijw d lwph] ;fn dksbZ gks] dks laiznf’kZr djsxkA
¼p½ mi;qZDr lkj.kh esa ;Fkk fofufnZ"V [kqnjk ;k izcyrk ;k nksuksa ds lkFk vuqlwfpr fofufeZfr dk dksbZ ekStwnk fofuekZrk
vkS”k/k ewY; fu;=a .k vkns'k] 2013 ds iSjk 2¼;w½ ds vuqlkj dksbZ ubZ vkS”kf/k dks ykap djrk gS rk s ,sls ekStwnk fofuekZrk dh
vkS”k/k ¼ewY; fu;=a .k½ vkns'k 2013 dh vuqlwph&II ds varxZr ;Fkk fofufnZ”V QkeZ&I esa ,uihih, dk s ,slh ubZ vkS”kf/k ds
iwoZ ewY; vuqekns u gsrq vkosnu djuk gkxs kA
¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼eYw ; fu;=a .k½
vkns'k] 2013 ds lwph II ds QkWeZ III dks vkbZihMh,e,l ds ek/;e ls Hkjdj ,uihih, dk s gj frekgh dh fjikVs Z izLrqr
djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gk s rks bldh lwpuk
,uihih, dks voxr djk;xs kA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk
bPNqd gS rk s cUn djus dh frfFk ls N% eghus igys vuqlwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA
¼Tk½ fofuekZrk ;k foi.ku dEiuh] mijkDs r dfFkr lkj.kh esa n'kkZ; s vf/kdre ewY; vkSj 'krk±s dk ikyu ugh a djrh ga S rks os
vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvk]s 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks
tek djus ds fy, mRrjnk;h gksaxAs
¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V ,ls h fofufeZfr;ksa ds iSdksa dh vf/kdre
dher fu;r gksus ds ifj.kkeLo#i] vf/kdre ;k [kqnjk ewY; fu/kkZfjr vkn's k ;fn dksbZ gks] tks fd bl vkns'k ls iwoZ tkjh
gq, gS] Lor% gh vf/kØe.k gks tk;saxAs
[पीएन/225/93/2021/एफ/फा.न.8(93)/2021/डी.पी./एनपीपीए-डी.वी.-II]
izlsuthr nkl] उप िनदेशक
ORDER
New Delhi, the 26th November, 2021
S.O. 4885(E).—In exercise of the powers conferred by paragraphs 4, 6, 10, 11, 14, 16, 17 and 18 of the
Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S.O. 701(E)
dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the
National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as
specified in column (5) of the table herein below as ceiling price exclusive of goods and services tax
applicable, if any, in respect of the Scheduled formulation specified in the corresponding entry in column (2)
of the said Table with the dosage form & strength and unit specified respectively in the corresponding
entries in columns (3) and (4) thereof:
TABLE
Sl. No. Name of the Dosage form & Strength Unit Ceiling
Scheduled Formulation Price (Rs.)
(1) (2) (3) (4) (5)
1. Methylthioninium chloride Injection 10mg/ml 1 ML 21.85
(Methylene blue)
2. Hydroxocobalamin Injection 1 mg/ml 1 ML 9.91
Note:
(a) All manufacturers of scheduled formulation, selling the branded or generic or both the versions of
scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as
applicable) so fixed and notified by the Government, shall revise the prices of all such formulations14 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)]
downward not exceeding the ceiling price specified in column (5) in the above table plus goods and
services tax as applicable, if any.
(b) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the
ceiling price specified in column (5) in the above table plus goods and services tax as applicable, if
any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO,
2013.
(c) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to
the Government on the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned
manufacturer in accordance with the ceiling price specified in column (5) of the above table as per
provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer
shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to
NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the
supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the
premises where he carries on business in a manner so as to be easily accessible to any person
wishing to consult the same.
(f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified
in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing
manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified
under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in
respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the
DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said
scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of
production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at
least six months prior to the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable
to deposit the overcharged amount along with interest thereon under the provisions of the Drugs
(Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above
table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above
said date of notification, stand(s) superseded.
[PN/225/93/2021/F/F. No. 8(93)/2021/D.P./NPPA-Div.-II]
PRASENJIT DAS, Dy. Director
Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.